• 1
    Holm HH, Juul N, Pedersen JF, Hansen H, Strøyer I. Transperineal 125 iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J. Urol. 1983; 130: 2836.
  • 2
    Crook J, Borg J, Evans A et al. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int. J. Radiat. Oncol. Biol. Phys. 2011; 80: 13239.
  • 3
    Sylvester JE, Grimm PD, Blasko JC et al. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int. J. Radiat. Oncol. Biol. Phys. 2007; 67: 5764.
  • 4
    Henry AM, Al-Qaisieh B, Gould K et al. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience. Int. J. Radiat. Oncol. Biol. Phys. 2010; 76: 506.
  • 5
    Saito S, Nagata H, Kosugi M, Toya K, Yorozu A. Brachytherapy with permanent seed implantation. Int. J. Clin. Oncol. 2007; 12: 395407.
  • 6
    Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur. Urol. 2002; 41: 42733.
  • 7
    Desai J, Stock RG, Stone NN, Iannuzzi C, DeWyngaert JK. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat. Oncol. Investig. 1998; 6: 13541.
  • 8
    Gutman S, Merrick GS, Butler WM et al. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy. BJU Int. 2006; 97: 628.
  • 9
    D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 96974.
  • 10
    KuPelian PA, Potters L, Khuntia D et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage TI-T2 prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004; 58: 2533.
  • 11
    Masters JG, Rice ML. Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores. BJU Int. 2003; 91: 7957.
  • 12
    Kumar V, Toussi H, Marr C, Hough C, Javle P. The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer. BJU Int. 2004; 93: 5079.
  • 13
    Matsubara A, Yoneda T, Yasumoto H et al. Lower urinary tract symptoms after radical perineal prostatectomy. Jpn. J. Clin. Oncol. 2007; 37: 5349.
  • 14
    Matsubara A, Yasumoto H, Mutaguchi K et al. Impact of radical perineal prostatectomy on urinary continence and quality of life: a longitudinal study of Japanese patients. Int. J. Urol. 2005; 12: 9538.
  • 15
    Merrick GS, Butler WM, Wallner KE, Allen Z, Galbreath RW, Lief JH. Brachytherapy-related dysuria. BJU Int. 2005; 95: 597602.
  • 16
    Ohashi T, Yorozu A, Toya K, Saito S, Momma T. Acute urinary morbidity following I-125 prostate brachytherapy. Int. J. Clin. Oncol. 2005; 10: 2628.
  • 17
    Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32: 46571.
  • 18
    Merrick GS, Butler WM, Wallner KE et al. The impact of radiation dose to the urethra on brachytherapy-related dysuria. Brachytherapy 2005; 4: 4550.
  • 19
    Petit JH, Gluck C, Kiger WS III et al. Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. Brachytherapy 2007; 6: 26771.
  • 20
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH. Long-term urinary quality of life after permanent prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003; 56: 45461.
  • 21
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med. Care 1998; 36: 100212.
  • 22
    Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J. Urol. 2000; 163: 8517.
  • 23
    Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J. Urol. 2001; 166: 94752.
  • 24
    Namiki S, Satoh T, Baba S et al. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Urology 2006; 68: 12306.
  • 25
    Namiki S, Ishidoya S, Ito A et al. Quality of life after radical prostatectomy in Japanese men: a 5-Year follow up study. Int. J. Urol. 2009; 16: 7581.
  • 26
    Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M. Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy. Jpn. J. Clin. Oncol. 2009; 39: 5028.
  • 27
    Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of healthrelated quality of life in men with prostate cancer. Urology 2000; 56: 899905.
  • 28
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J. Urol. 2007; 177: 21516.
  • 29
    Sanda MG, Dunn RL, Michalski J et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 2008; 358: 125061.
  • 30
    Ferrer M, Suarez JF, Guedea F et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008; 72: 42132.
  • 31
    Litwin MS, Gore JL, Kwan L et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007; 109: 223947.
  • 32
    Kakehi Y, Takegami M, Suzukamo Y et al. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the expanded prostate cancer index composite. J. Urol. 2007; 177: 185661.